SC asks petitioner to approach NGT on FGD systems in thermal plants

New Delhi, Sept. 8 -- The Supreme Court on Tuesday asked a petitioner seeking time-bound installation and operationalisation of flue gas desulphurisation (FGD) systems in all category 'A' thermal powe... Read More

People must vote against BJP to deflate its arrogance: Congress' Khachariyawas attacks Rajasthan govt over law and order, development

Jaipur, Sept. 8 -- Senior Congress leader Pratap Singh Khachariyawas on Tuesday attacked the BJP government in Rajasthan over the state's law and order, healthcare and development, alleging that the g... Read More

61-year-old Karnataka resident declared dead in draft voter roll visits officials

India, Sept. 8 -- Donald Joseph Rego (61) had no reason to prove that he was alive. Until the draft electoral roll published on August 24 under the ongoing special intensive revision (SIR) told him ot... Read More

Delhi PG collapse: Plea to seek action expansion against illegal constructions

India, Sept. 8 -- A plea is expected to be mentioned before the Supreme Court on Tuesday, seeking an urgent expansion of the court-monitored exercise against illegal constructions and unauthorised cha... Read More

Secunderabad Cantt theft: Army Major being interrogated

Hyderabad, Sept. 8 -- With no breakthrough in the firearm theft case from the Madras Regiment armoury in Bollaram, investigators have shifted the lens on the officers responsible for supervising the f... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event – MOVE-Lp(a)

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvala... Read More

Singapore Clinical Trial: FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More

Singapore Clinical Trial: A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum- Sensitive Ovarian Cancer (PSOC)

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More

Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More

Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More

• ««
• «
• 914
• 915
• 916
• 917
• 918
• 919
• 920
• 921
• 922
• 923
• »
• »»